ArticleMicrobiology spectrum2026
PstSCAB and SapBCDF are putrescine exporters in
Yuta Sugiyama, Atsuo Nakamura, Hirokazu Ohta, Tsuyoshi Fujita, Yuki Kontani, Hiromi Shimokawa, Rika Hirano, Yuta Ami, Mikiyasu Sakanaka, Mitsuharu Matsumoto and 1 more
Abstract read
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Yuta SugiyamaFaculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan.ORCID 0000-0002-8929-0854 Atsuo NakamuraDairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd, Hinode, Tokyo, Japan.
Hirokazu OhtaFaculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan.
Tsuyoshi FujitaFaculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.
Yuki KontaniFaculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.
Hiromi ShimokawaFaculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.
Rika HiranoFaculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan.
Yuta AmiFaculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.
Mikiyasu SakanakaFaculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan.ORCID 0000-0002-4223-0926 Mitsuharu MatsumotoDairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd, Hinode, Tokyo, Japan.ORCID 0000-0002-0378-3077 Shin KuriharaFaculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan.ORCID 0000-0002-2756-4629 Funding
Institute for Fermentation, Osaka K-25-04Japan Society for the Promotion of Science 17H05026, 20H02908
6 · The paper itselfAbstract
IMPORTANCE: Antibiotics are the primary treatment for bacterial urinary tract infections (UTIs). However, overuse of antibiotics promotes the emergence of antibiotic-resistant bacteria; therefore, it is desirable to develop drugs that specifically inhibit virulence without promoting the emergence of antibiotic resistance.
Indexed as
Bacterial ProteinsMembrane Transport ProteinsProteus mirabilisPutrescineAntiportersBiological TransportHumansProteus InfectionsUrinary Tract InfectionsAntiportersBacterial ProteinsMembrane Transport ProteinsPutrescineABC transporterspolyaminesProteus mirabilisputrescineswarmingurinary tract infection
Identifiers
PMID41235918
PMCPMC12772348
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390